| Revenues: | |
| Clinical laboratory services | 13.32M |
| Product revenues | 7.88M |
| Royalty and license fee income | 1.01M |
| Total revenues | 22.21M |
| Operating expenses: | |
| Cost of clinical laboratory services | 9.43M |
| Cost of product revenues | 4.14M |
| Research and development | 968K |
| Selling, general, and administrative | 10.89M |
| Provision for uncollectible accounts receivable | 1.34M |
| Legal | 1.44M |
| Total operating expenses | 28.2M |
| Operating loss | -5.99M |
| Other income (expense): | |
| Interest | -7K |
| Other | 43K |
| Foreign currency gain (loss) | 104K |
| Loss before income taxes | -5.85M |
| Benefit (provision) for income taxes | 180K |
| Net loss | -5.67M |
| Net loss per common share: | |
| Basic and diluted (in Dollars per share) | -0.14 |
| Weighted average common shares outstanding: | |
| Basic and diluted (in Shares) | 39.31K |